emedastine has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, T; Hashimoto, N; Ishibashi, R; Miyamoto, S; Nishimura, M | 1 |
| Katayama, I; Nishioka, K; Sasaki, G; Satoh, T; Wu, MH; Yokozeki, H | 1 |
| Montero, JA; Pastor, S; Rodriguez, AE; Ruiz-Moreno, JM; Sanchis-Merino, ME | 1 |
3 other study(ies) available for emedastine and Disease Models, Animal
| Article | Year |
|---|---|
Contribution of mast cells to cerebral aneurysm formation.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arteries; Benzimidazoles; Blood Pressure; Cell Degranulation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Intercellular Signaling Peptides and Proteins; Interleukin-1beta; Intracranial Aneurysm; Male; Mast Cells; Matrix Metalloproteinases; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type II; ortho-Aminobenzoates; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Time Factors | 2010 |
Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Arylsulfonates; Benzimidazoles; Cell Count; Dermatitis, Allergic Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; Interleukin-4; Interleukin-5; Leukocyte Count; Lymph Nodes; Mice; Phthalazines; Picryl Chloride; Skin; Spleen; Sulfonium Compounds | 2003 |
Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
Topics: Animals; Anti-Allergic Agents; Benzimidazoles; Coloring Agents; Conjunctivitis, Allergic; Dibenzoxepins; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Evans Blue; Guinea Pigs; Histamine H1 Antagonists; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines; Severity of Illness Index; Treatment Outcome | 2008 |